心血管和非酒精性脂肪肝疾病:通过SIRT1通路分享共同的基础
1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20810, United States. wntin75@yahoo.com.
World journal of cardiology
|November 27, 2024
概括
心血管和肝脏疾病,包括非酒精性脂肪性肝病 (NAFLD),共享一种涉及SIRT1.1的共同细胞通路. 向SIRT1可能为这些普遍的非传染性疾病提供新的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 非酒精性脂肪性肝病 (NAFLD) 是一种日益增长的肝病原因,通常与诸如糖尿病 (DM) 等代谢障碍同时发生.
- 患有代谢障碍的人患心脏病,中风和肝脏疾病的风险明显更高,包括NAFLD.
研究的目的:
- 探索心血管疾病和NAFLD之间的共享细胞机制.
- 调查沉默交配类型信息规则2同类型1 (SIRT1) 在这些疾病的病理学中的作用.
- 评估针对治疗干预的SIRT1通路的潜力.
主要方法:
- 对有关心血管疾病,NAFLD和SIRT的现有文献的综述1.
- 分析涉及SIRT1,尼古丁胺胺氨基二核酸和相关因素的分子途径.
- 探索SIRT1在细胞保护机制中的作用.
主要成果:
- 心血管疾病和NAFLD共享SIRT1作为一个共同的潜在细胞机制.
- SIRT1是一种基因素脱乙酶,与代谢途径和细胞保护有关.
- SIRT1会影响红色素,干细胞和AMP激活蛋白激酶等热带因素.
结论:
- 在心血管和肝脏疾病中,SIRT1通路是潜在的治疗点.
- 进一步研究SIRT1通路的复杂性对于开发有效的临床治疗至关重要.
- 准SIRT1为管理这些广泛的非传染性疾病提供了希望.
相关概念视频
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Cholesterol: Significance and Regulation
510
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
510
Diseases of the Liver and Gallbladder
475
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
475
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


